Ambac Financial Group INC

Market Movers (8-K)

Octave Specialty Group, Inc. successfully concluded its 2026 Annual Meeting, confirming director elections and executive compensation plans.
Octave Specialty Group announced robust first quarter 2026 financial results, driven by significant growth in its Insurance Distribution segment and a turnaround in its Specialty P&C Insurance segment.
Octave Specialty Group, Inc. has amended its credit agreement, securing an additional $40 million term loan to fund obligations related to minority shareholder put rights.
Capital raise
Octave Specialty Group reported a transformational fourth quarter 2025, becoming a pure-play specialty P&C company with strong insurance distribution growth despite a consolidated net loss.
Octave Specialty Group, Inc. finalized its $250 million acquisition of ArmadaCorp Capital, LLC, expanding its insurance and healthcare services portfolio.
Worse than expected
Octave Specialty Group, Inc. announced the appointment of Ernst & Young LLP as its new independent registered public accounting firm for the fiscal year 2026, replacing KPMG LLP after a competitive review process.

Quarterly Earnings (10-Q)

Octave Specialty Group reports Q1 2026 financial results highlighting growth in its insurance distribution segment and strategic debt restructuring.
Worse than expected
Capital raise
Ambac Financial Group reported a significant net loss for Q3 and the nine months ended September 30, 2025, primarily driven by the sale of its Legacy Financial Guarantee business, while strategically expanding its Insurance Distribution segment through acquisitions.
Worse than expected
Capital raise
Ambac Financial Group reported a significant net loss in Q2 2025, primarily driven by a loss on the pending sale of Ambac Assurance Corporation (AAC), while extending its short-term debt maturity.
Delay expected
Worse than expected
Capital raise
Ambac Financial Group reports a net loss for Q1 2025, impacted by the pending sale of AAC and increased expenses in its Insurance Distribution segment.
Worse than expected
Capital raise
Delay expected
Ambac Financial Group's third quarter 2024 results reflect a period of strategic transition, including the pending sale of its legacy financial guarantee business and the acquisition of Beat Capital Partners.
Worse than expected
Ambac Financial Group's second quarter 2024 results reflect ongoing business operations and strategic moves, including a pending sale of its legacy financial guarantee business and an acquisition in the insurance distribution sector.
Worse than expected

Annual Reports (10-K)

Octave Specialty Group, formerly Ambac Financial Group, completed its pivot to specialty property & casualty and insurance distribution, reporting a higher net loss from continuing operations in 2025 despite revenue growth driven by acquisitions.
Capital raise
Worse than expected
Ambac Financial Group's 2024 results reflect a company in transition, highlighted by the pending sale of AAC and strategic focus on Insurance Distribution and Specialty P&C Insurance businesses.
Worse than expected
Ambac Assurance Corporation is subject to a new stipulation and order from the Wisconsin Office of the Commissioner of Insurance, impacting its surplus and operational practices.
Worse than expected

Insider Trading (Form 4)

Claude Leblanc, Chief Executive Officer and a Director of Ambac Financial Group Inc, reported multiple transactions in common stock on July 9, 2026.
R Sharon Smith, Exec VP & Group COO of Ambac Financial Group Inc, reported multiple transactions in common stock on July 9, 2026.
David Trick, Exec VP, CFO & Treasurer of Ambac Financial Group Inc, reported multiple transactions in common stock on July 9, 2026.
Octave Specialty Group, Inc. reports the grant of restricted stock units to Director Jeffrey Scott Stein.
Michael D. Price, a Director at Octave Specialty Group Inc., acquired 6,500 Restricted Stock Units (RSUs) on July 1, 2026, with vesting scheduled for July 1, 2027.
Octave Specialty Group, Inc. reports that Director Kristi Ann Matus was granted 6,500 Restricted Stock Units (RSUs) on July 1, 2026, vesting one year later.

Proxy Statements (Def-14A)

Octave Specialty Group, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders, scheduled for May 28, 2026, to be held virtually.
Ambac Financial Group, Inc. announces its 2025 Annual Meeting of Stockholders, detailing proposals for director elections, executive compensation, auditor ratification, and frequency of executive compensation votes.
Ambac Financial Group's proxy statement outlines key business highlights, executive compensation details, and proposals for the 2025 Annual Meeting of Stockholders.
Better than expected
Ambac Financial Group provides supplemental disclosures to its proxy statement regarding the proposed sale of Ambac Assurance Corporation (AAC) to Oaktree Capital Management, addressing stockholder demand letters and complaints alleging disclosure deficiencies.
Ambac Financial Group is urging its stockholders to vote in favor of the Sale Proposal, Compensation Proposal, and Adjournment Proposal at the special meeting scheduled for October 16, 2024, regarding the proposed sale of AAC to American Acorn Corporation.
Ambac Financial Group is urging its stockholders to vote in favor of the proposed sale of Ambac Assurance Corporation to American Acorn Corporation, owned by Oaktree Capital Management, at a special meeting on October 16, 2024.

Schedule 13G - Passive Investments

Vanguard Capital Management has reported beneficial ownership of 5.04% of Octave Specialty Group Inc.'s common stock as of June 30, 2026.
Western Standard LLC and Eric D. Andersen have reported a 4.99% beneficial ownership stake in Octave Specialty Group, Inc.
Jane Street Group and its affiliates have reported beneficial ownership of 1.7% of Octave Specialty Group Inc.'s common stock as of March 31, 2026.
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Octave Specialty Group Inc following an internal realignment.
Worse than expected
Western Standard LLC has reported a 5.87% beneficial ownership stake in Octave Specialty Group, Inc., holding 2,572,446 shares of common stock.
Jane Street Group and its affiliates have reported a 5.4% beneficial ownership stake in Octave Specialty Group Inc. common stock.